Cargando…
In the VEST trial: are we missed to address the pathology incurred by the external stent?
In the VEST IV trial, the author concluded that external stenting of saphenous vein graft mitigates its remodeling and also significantly reduces the diffuse intimal hyperplasia and development of lumen irregularities at 4.5 years after coronary artery bypass grafting surgery. We also have valuable...
Autores principales: | Palanisamy, Vijayanand, Kurian, Valikapthalil Mathew, sethuratnam, Rajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425144/ https://www.ncbi.nlm.nih.gov/pubmed/34496907 http://dx.doi.org/10.1186/s13019-021-01640-6 |
Ejemplares similares
-
Technical Aspects: Coronary Artery Bypass Grafting in a Case of Dextrocardia With Situs Inversus
por: Ravikumar, Mithun Sundararaaja, et al.
Publicado: (2021) -
Role of LQ Model to Address Effect of Missed Treatment Days in External-Beam Radiotherapy
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2021) -
Timeliness: The Authors' Vested Right but the Editors' Last Concern
por: Rad, Mostafa, et al.
Publicado: (2016) -
Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial
por: Taggart, David P., et al.
Publicado: (2018) -
The Royal Hospital for Incurables
por: Helena,
Publicado: (1915)